An accomplished start-up and small pharma entrepreneurial scientist with extensive knowledge, experience, and achievement in a wide range of drug discovery and development programs. A respected leader of multi-disciplinary research teams with a strong record of identifying and developing novel assets whether emerging therapeutic targets or novel compounds, ranging from small molecules to biologicals. Experienced in both sell-side and buy-side deal crafting with a strong understanding of the requirements for raising capital and how to manage programs on limited budgets and tight time lines, including the use of virtual resources to achieve corporate goals